Introduction: Why companies fail when they import medicinal products into the EU

Do you need to import medicinal products into the EU? If you are reading this, you are probably planning to import medicinal products into the EU for the first time and you have realized it is not as simple as just shipping boxes from India, China, the US or the UK. You want to import medicinal products into the EU correctly, pass HPRA inspections, and avoid your batch being stuck in quarantine for months.

I have audited more than 50 importer sites and I have seen the same story: a company finds a great supplier, pays for the first batch, ships it to Dublin, and then it gets stuck in quarantine for 4 months because they tried to import medicinal products into the EU without an MIA, without a QP, and without understanding Annex 21. That batch cannot be sold, cannot be moved, and burns cash every day in storage fees. In Europe, the law is very clear. 

If you import medicinal products into the EU, the law treats you as if you manufactured it yourself. That means you are responsible for GMP, quality, testing, recalls, and patient safety, just like a factory. In this complete guide, I will show you exactly how to import medicinal products into the EU step-by-step.

What does it really mean to import medicinal products into the EU?

Let’s start with the legal definition, because this is where most confusion comes from. According to EU GMP Annex 21, “import” is defined as the physical introduction of a medicinal product from outside the territory of the EEA/EU. That definition is critical when you import medicinal products into the EU.

So what counts as import? Any time you bring a medicinal product from a third country into the EU customs territory. For example, US to Ireland is an import. India to Germany is an import. China to Malta is an import. 

Since Brexit on January 1st 2021, UK to Ireland, UK to France, UK to any EU country, that is also an import. Even if your UK supplier was your partner for 20 years, today when you import medicinal products into the EU from the UK, you need full import controls, an MIA, and QP certification.

What does NOT count as import? Moving goods inside the EU. France to Ireland is not an import, it is distribution. You need a Wholesale Distribution Authorisation (WDA), not an MIA. Many companies confuse this when they import medicinal products into the EU via a UK hub.

Here is the rule that catches 90% of first-time companies who want to import medicinal products into the EU: The batch is not legal to sell just because it landed at Dublin Airport, Shannon, or passed customs. EU law says the release of batches of medicines by an EUQP can only take place after physical import and customs clearance in the EU/EEA state. That is a direct quote from the EU guidance on third country import. You cannot do EUQP certification while the goods are still sitting in a third-country warehouse in New Jersey, Mumbai, or London. The product must be physically in the EU, under your MIA, in QUARANTINE status, before the EUQP can certify it. This is one of the most important points when you import medicinal products into the EU.

This is defined in EudraLex Volume 4, which is the collection of all EU GMP guidelines. If you want to understand the differences between regimes, I wrote a detailed comparison here: EU vs non-EU pharma import regulations.

Why is the EU so strict? Because supply chains have become global and complex. Ten years ago, most medicines for the EU market were made inside the EU. Now, most active pharmaceutical ingredients (APIs) and many finished products are made outside the EU in third countries. To protect patients, the EU says: if you import medicinal products into the EU, you must hold a Manufacturing Import Authorisation (MIA) and follow GMP, just like a manufacturer. This applies to every company that wants to import medicinal products into the EU, whether you are a start-up or a big pharma.

How to import medicinal products into the EU: The 5 steps that actually matter

If you want to import medicinal products into the EU without 3-month delays, you need to do these 5 steps in the exact order. The biggest mistake I see is companies ordering stock before step 1 and 2 are done. Don’t do it. If you want to import medicinal products into the EU successfully, follow this sequence.

1. Get your Manufacturing Import Authorisation (MIA) – Your licence to import medicinal products into the EU

Without an MIA licence, you cannot legally import medicinal products into the EU. Period. In Ireland, the Health Products Regulatory Authority (HPRA) issues it. In Germany it is the local Landesbehörde, in Malta it is the Malta Medicines Authority. But the requirements are almost identical across the EU because they all come from the same EU law and Annex 21.

To get your MIA to import medicinal products into the EU, you need to prove four pillars to the inspector: Pillar A is Premises and Equipment. You need a GMP-compliant warehouse, not just any logistics warehouse. That means full temperature mapping of your warehouse in both winter and summer to prove there are no hot or cold spots. You need 24/7 continuous temperature monitoring with calibrated probes, with SMS and email alarms if temperature goes out of range. You need backup power or a clear procedure for power failure. And you must have two physically and systematically separated areas: QUARANTINE for goods that have been imported but not yet QP certified, and RELEASED (saleable) for goods that have been QP certified. If your WMS system allows you to sell from QUARANTINE, you will fail inspection when you try to import medicinal products into the EU.

Pillar B is People. You must have key personnel named on your MIA. That includes Head of Quality, Head of Production/Importation, and a Qualified Person (QP). You cannot just say “we will hire a QP later”. The HPRA will interview your QP and Head of Quality during inspection. They need to be experienced and available. This is crucial when you import medicinal products into the EU.  Your QP will be named on your MIA licence, no QP means no MIA licence.

Pillar C is Pharmaceutical Quality System (PQS). This is a set of SOPs that proves you control quality. You need SOPs for supplier qualification, for managing complaints and recalls, for deviations and CAPAs, for change control, for self-inspection, for batch reveiw & certification, for batch traceability, and for managing your supply chain. This PQS is where 70% of companies fail first inspection to import medicinal products into the EU.

Pillar D is Written Agreements. You need Technical Agreements (also called Quality Agreements) between you and every party involved: the third-country manufacturer, the importation QC testing lab, the QP certification site if different from your import site, the transport companies, and the Marketing Authorisation Holder (MAH).

I wrote exactly what inspectors check during an HPRA audit and the 12 most common deficiencies here: EU GMP requirements for importers. Read it before you apply. This process takes 3-6 months in Ireland, sometimes 9 months in larger countries. So if you plan to import medicinal products into the EU in Q2 2027, you should start your MIA application now.

2. Master GMP Annex 21 – Your bible to import medicinal products into the EU

EU GMP Annex 21 was released in August 2022 and implemented in August 2023. It was written specifically for companies that import medicinal products into the EU. Before Annex 21, rules were scattered across EU GMP Annex 16, Chapter 1, Chapter 7. Now everything for importers is in one place, which makes it easier when you import medicinal products into the EU.

Annex 21 defines two critical sites you must understand: Site of Physical Import (where the truck physically arrives and customs clearance happens) and Site of QP Certification (where the QP reviews the documentation and certifies the batch as released for sale). They can be the same building in Ireland, or they can be split – for example, physical import in the Netherlands and QP certification in Ireland. Both sites must be listed on an MIA when you import medicinal products into the EU.

What does Annex 21 require in daily practice when you import medicinal products into the EU? Three non-negotiable things. First, documentation before shipment. Before the product even takes off from the third country, you must already have at the import site: the batch manufacturing record copy, the batch certificate of analysis from the third-country manufacturer, the GMP certificate of the third-country manufacturing site (proving it was audited by an EU authority), the approved marketing authorization details, stability data, Product Quality Reviews and transport conditions. If these are not available before you import medicinal products into the EU, the batch cannot be QP certified.

Second, prove the transportation temperature was maintained with data (this could be ambient or cold chain shipping conditions). If your product label says “store at 2-8°C” or “store below 25°C”, you must prove with continuous data loggers that it never left that range from the factory in a third country to your warehouse. Annex 21 says relevant ordering and delivery documentation, including transportation details like temperature monitoring records, should be included in batch documentation. If you have a 2-hour excursion and no stability data to justify it, your EUQP cannot release it when you import medicinal products into the EU.

Third, quarantine and no manipulation. Once it lands, the batch must go straight into QUARANTINE status, both physically and in your ERP/WMS system. You cannot re-label it, re-pack it, put FMD codes, or sell a single unit until the importation QC testing and QP certification is done. This is a GMP rule when you import medicinal products into the EU, not just best practice.

3. The Qualified Person (QP) – The gatekeeper when you import medicinal products into the EU

The QP is the most important person in the entire process when you import medicinal products into the EU. In the US, this role does not exist. In the EU, it is defined by law in Directive 2001/83/EC. To be a QP, you need to be a pharmacist, chemist, biologist with years of university plus 2-3 years industrial experience in GMP.

What does the QP actually do? For every single batch you import, when you import medicinal products into the EU, the QP must check: Is the third-country factory GMP compliant and covered by a valid GMP certificate? Was the batch made according to the EU Marketing Authorisation? Do we have full batch documentation at the MIA site? Is there clear traceability and quantity reconciliation if the batch was split? Are there transport records and temperature data? Has EU re-testing been done if required because there is no MRA? Is there an ongoing stability program and are reference and retention samples taken correctly? Only after all these checks, and only after physical import and customs clearance, can the QP certify the batch and release it to saleable stock when you import medicinal products into the EU. That QP signature makes your batch legal to sell in all 30 EEA countries.

If you don’t have a QP in-house, you can outsource QP certification to a company like QbD or Inglasia who holds an MIA for QP certification. Learn the full QP checklist here: what EU batch release means.

4. The batch testing trap – Why 60% of first imports fail when you import medicinal products into the EU

This is the step where most companies that import medicinal products into the EU get stuck, lose 3 weeks, and pay €5k extra. EU law says: Where there is no mutual recognition agreement (MRA), it is a legal requirement to test each batch upon import into the EU prior to certification and release. This is Article 51(1)(b) for human medicines. This rule is critical when you import medicinal products into the EU.

What does it mean in plain English? If your product comes from a country with which the EU does NOT have a full MRA covering your product type, you MUST re-test the full batch in an EU GMP-compliant QC laboratory, even if it was already tested perfectly in the third country. Examples: Product from India – no MRA, must re-test in EU. Product from China – no MRA, must re-test. Product from USA – there is an MRA but it is partial and does NOT cover all products like vaccines, plasma products, and many biologics – so for many products you still must re-test when you import medicinal products into the EU. Product from Switzerland – full MRA, usually no full re-test needed, only verification is required.

The requirements for where the testing should be carried out and minimum testing requirements are in EU law. The QC methods must be validated or transferred from the third-country site to your EU lab, which itself takes 2-4 weeks. You must check the current MRA list on the official European Medicines Agency (EMA) website and on the European Commission website for your exact product type and country. If re-testing is required, budget €2,500-€6,000 per batch and 15-20 working days. This is not optional when you import medicinal products into the EU.

See our detailed timeline with testing included here: step-by-step EU pharmaceutical import process.

5. Customs, VAT, FMD, and full traceability when you import medicinal products into the EU

The final step when you import medicinal products into the EU is not just customs clearance. Many companies think once customs releases it, they can sell it. Wrong. Customs release is step 1 of 5 in this section. When you import medicinal products into the EU, you need to think about customs, VAT, labelling, Falsified Medicines Directive (FMD), and traceability.

At customs, you must have an EORI number, a VAT number, and you must declare the goods as medicinal products with the correct HS code (usually 3004). You must present your MIA licence number at import. Duties are often 0% for medicines, but VAT (23% in Ireland) is payable at import and later reclaimable. You also need a customs broker who understands pharma – a normal broker often misclassifies medicines as chemicals when you import medicinal products into the EU.

For labelling, the outer carton must show your EU MIA holder name and address as the importer/manufacturer, not the third-country factory address. It must show batch, expiry, and local language per country. And under the EU Falsified Medicines Directive (FMD), you must have safety features: a unique identifier encoded in a 2D data matrix code with product code, serial number, expiry, and batch, plus an anti-tampering device. You must decommission and re-commission FMD codes correctly if you re-pack when you import medicinal products into the EU.

Finally, Annex 21 requires importing MIA entities to maintain clear traceability of the supply chain, from manufacturing to distribution, at all times when you import medicinal products into the EU. That means you need to keep ordering documentation, delivery notes, airway bills, temperature loggers, invoices, batch records, CoAs, GMP certificates, QC results, and QP certificates for every batch for at least 1 year after expiry. You also need a Product Quality Review where you compare EU lab results vs third-country CoA.

We listed the 7 most common pitfalls that cause QP to refuse release here: common compliance mistakes in EU pharma importation.

Final checklist: How to import medicinal products into the EU without delays

To import medicinal products into the EU successfully and pass your first HPRA inspection with no critical deficiencies, remember four words I tell all clients: Legal, Tested, Documented, Certified. 

• Legal means you have your MIA, your WDA if you also distribute, and all Technical Agreements signed before first shipment. 
• Tested means your EU QC lab is qualified, methods transferred, and you have budgeted time and money for re-testing if there is no MRA. 
• Documented means you have batch records, CoAs, GMP certificates, transport data, and quantity reconciliation BEFORE the plane takes off. 
• Certified means your QP has physically reviewed everything after you import medicinal products into the EU and signed the QP certification.

If one of those four is missing, your batch stays in QUARANTINE and you cannot invoice it. The companies that succeed to import medicinal products into the EU secure their MIA and QP 4-6 months before their first commercial shipment and they run a mock import with a small test batch to test the system end-to-end. If you plan to import medicinal products into the EU in the next 6 months, start now. Secure your import site, talk to a QP, check your MRA status, and prepare your Annex 21 checklist. That is how you avoid 4 months of quarantine and launch on time when you import medicinal products into the EU.